TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06134167: A Prospective, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Effectiveness of the Transdermal Compress Device in Participants With Transfemoral Amputations

Sponsor: Balmoral Medical company · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 100 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$6,640,000

Rescue Site Savings

+$4,382,400

Unlock Full NCT06134167 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06134167 Rescue Dossier →